Avirup Guha
Overview
Explore the profile of Avirup Guha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
2265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang S, Patel V, Stabellini N, Datta B, Nain P, Seth L, et al.
J Natl Compr Canc Netw
. 2025 Mar;
:1-9.
PMID: 40073832
Background: Rural areas have higher cardiovascular disease (CVD) incidence and age-adjusted mortality rates in the general population. However, the impact of rurality on CVD development and outcomes in patients with...
2.
Guha A, Shah V, Nahle T, Singh S, Kunhiraman H, Shehnaz F, et al.
Curr Cardiol Rep
. 2025 Feb;
27(1):56.
PMID: 39969610
Purpose Of Review: This review explores the role of artificial intelligence (AI) in cardio-oncology, focusing on its latest application across problems in diagnosis, prognosis, risk stratification, and management of cardiovascular...
3.
Stabellini N, Makram O, Kunhiraman H, Daoud H, Shanahan J, Montero A, et al.
JNCI Cancer Spectr
. 2025 Jan;
9(1).
PMID: 39883570
Background: Cancer patients have up to a 3-fold higher risk for cardiovascular disease (CVD) than the general population. Traditional CVD risk scores may be less accurate for them. We aimed...
4.
Dent S, Guha A, Moore H, Makari D, McCaleb R, Arias I, et al.
Cardiooncology
. 2025 Jan;
11(1):7.
PMID: 39871392
Background: Cardiovascular (CV) comorbidities and concurrent medications with risk of heart rate-corrected QT interval (QTc) prolongation can impact treatment decisions and safety discussions for patients with breast cancer. However, limited...
5.
Leong D, Guha A, Morgans A, Niazi T, Pinthus J
JACC CardioOncol
. 2025 Jan;
6(6):835-846.
PMID: 39801649
Cardiovascular disease is common in patients with prostate cancer and is a significant cause of death. Cardiovascular risk factors are frequent in this population and are often not addressed to...
6.
Agarwal S, Qamar U, Khan M, Al-Juhaishi T, Naqash A, Guha A, et al.
Eur Heart J Open
. 2025 Jan;
5(1):oeae101.
PMID: 39781540
Aims: We aimed to perform a retrospective cohort study using the Centers for Disease Control and Prevention's (CDC's) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database to analyse the trends...
7.
Echefu G, Batalik L, Lukan A, Shah R, Nain P, Guha A, et al.
Curr Treat Options Cardiovasc Med
. 2024 Nov;
27(1).
PMID: 39610711
Purpose Of Review: A critical evaluation of contemporary literature regarding the role of big data, artificial intelligence, and digital technologies in precision cardio-oncology care and survivorship, emphasizing innovative and groundbreaking...
8.
Makram O, Nain P, Vasbinder A, Weintraub N, Guha A
Cardiol Clin
. 2024 Nov;
43(1):1-11.
PMID: 39551552
This review goes beyond traditional approaches in cardio-oncology, highlighting often-neglected factors impacting patient care. Social determinants, environment, health care access, and gut microbiome significantly influence patient outcomes. Powerful tools like...
9.
Ashkarran A, Gharibi H, Sadeghi S, Modaresi S, Wang Q, Lin T, et al.
Nat Commun
. 2024 Nov;
15(1):9638.
PMID: 39511193
The protein corona formed on nanoparticles (NPs) has potential as a valuable diagnostic tool for improving plasma proteome coverage. Here, we show that spiking small molecules, including metabolites, lipids, vitamins,...
10.
Leong D, Fradet V, Niazi T, Selvanayagam J, Sabbagh R, Higano C, et al.
JACC CardioOncol
. 2024 Oct;
6(5):761-771.
PMID: 39479325
Background: There are limited data on the physical effects of androgen deprivation therapy (ADT) for prostate cancer (PC), and on the relationships of such measures of adiposity and strength to...